Cargando…
Effect of Prophylactic Use of Silymarin on Anti-tuberculosis Drugs Induced Hepatotoxicity
BACKGROUND: The first line of anti-tuberculosis (TB) drugs are the most effective standard of drugs for TB. However, the use of these drugs is associated with hepatotoxicity. Silymarin has protective effects against hepatotoxicity of anti-TB drugs in animal models. This study aims to investigate the...
Autores principales: | Heo, Eunyoung, Kim, Deog Kyeom, Oh, So Hee, Lee, Jung-Kyu, Park, Ju-Hee, Chung, Hee Soon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Tuberculosis and Respiratory Diseases
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526953/ https://www.ncbi.nlm.nih.gov/pubmed/28747959 http://dx.doi.org/10.4046/trd.2017.80.3.265 |
Ejemplares similares
-
The clinical impact of drug-induced hepatotoxicity on anti-tuberculosis therapy: a case control study
por: Song, Jin Hwa, et al.
Publicado: (2019) -
Risk factors for pulmonary arterial hypertension in patients with tuberculosis-destroyed lungs and their clinical characteristics compared with patients with chronic obstructive pulmonary disease
por: Jo, Yong Suk, et al.
Publicado: (2017) -
Discordance between MTB/RIF and Real-Time Tuberculosis-Specific Polymerase Chain Reaction Assay in Bronchial Washing Specimen and Its Clinical Implications
por: Jo, Yong Suk, et al.
Publicado: (2016) -
The effect of obesity on patients with mild chronic obstructive pulmonary disease: results from KNHANES 2010 to 2012
por: Park, Ju-Hee, et al.
Publicado: (2017) -
The Effectiveness of Silymarin in the Prevention of Anti-tuberculosis Drug-induced Hepatotoxicity: A Randomized Controlled Clinical Trial
por: Talebi, Ali, et al.
Publicado: (2023)